59Indexed trials
mesh condition
Substance-Related Disorders
Intelligence
Substance-Related Disorders intelligence: 59 indexed trials, 16 recruiting studies, 47 sponsors across 15 countries.
16Recruiting
47Sponsors
15Countries
Leading sponsors
Medical University of South Carolina30 recruiting
Johns Hopkins University30 recruiting
University of California, Los Angeles20 recruiting
National Institute on Drug Abuse (NIDA)20 recruiting
University of California, San Francisco21 recruiting
Dartmouth-Hitchcock Medical Center20 recruiting
Baylor College of Medicine20 recruiting
Karolinska Institutet20 recruiting
Massachusetts General Hospital20 recruiting
UConn Health20 recruiting
Icahn School of Medicine at Mount Sinai10 recruiting
Children's Hospital of Philadelphia10 recruiting
Geographic activity
United States36trials
China3trials
Germany2trials
Sweden2trials
France2trials
Netherlands1trials
South Korea1trials
Spain1trials
Switzerland1trials
United Kingdom1trials
Mexico1trials
Canada1trials
Leading interventions
Treatment as usual3trials
Saline2trials
Oxytocin2trials
Adapted Cognitive Behavioral Intervention for Trauma in Schools (CBITS) with a Racial Trauma Module (RTM)1trials
Audiovisual Entrainment1trials
Breathwork-Based Auditory Driving Entropy Module (BADEM)1trials
Assessment only of alcohol and drug use.1trials
Bupropion SR1trials
CALM-SUD1trials
CIDI-51trials
Candesartan1trials
Bupropion1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.